Glucotrack (GCTK) Current Assets (2010 - 2025)

Glucotrack has disclosed Current Assets across 16 years of filings, most recently posting $7.7 million for Q4 2025.

• Quarterly Current Assets rose 32.92% year-over-year to $7.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.7 million (up 32.92% YoY) and the FY2025 annual result came in at $7.7 million, up 32.92% from the prior year.
• Current Assets retreated to $7.7 million in Q4 2025, from $8.1 million in the prior quarter.
• Over five years, Current Assets peaked at $10.1 million in Q2 2025 and troughed at $442000.0 in Q2 2024.
• A 5-year average of $5.6 million and a median of $5.9 million in 2021 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2024 — Current Assets tumbled 95.06% — and 2025, when it surged 2179.86%.
• Tracing GCTK's Current Assets over 5 years: stood at $6.1 million in 2021, then slumped by 61.03% to $2.4 million in 2022, then surged by 104.62% to $4.9 million in 2023, then advanced by 18.49% to $5.8 million in 2024, then soared by 32.92% to $7.7 million in 2025.
• Business Quant data shows GCTK's Current Assets at $7.7 million in Q4 2025, $8.1 million in Q3 2025, and $10.1 million in Q2 2025.